Mesothelioma Specialists
A specialist who routinely cares for mesothelioma patients is aware of what to look out for on blood tests, imaging tests and other diagnostic tools. Doctors who specialize in mesothelioma can also provide advanced treatment that can improve the prognosis.
Be aware of experience, hospital affiliation, and availability when choosing mesothelioma specialists. Patients must feel comfortable and supported during each visit.
Raja Flores
Dr. Raja Flores, a mesothelioma expert who has a good reputation for his surgical and patient care expertise, is highly regarded for his expertise. He is the director of thoracic surgery at Mount Sinai Medical Center, New York City.
Flores developed his skills in treating lung cancer and mesothelioma during his time at Brigham and Women's Hospital. He was trained by renowned mesothelioma specialist Dr. David Sugarbaker. He is an expert in treating lung cancer, pleural cancer, and esophageal carcinoma.
He helped pioneer the lung-sparing pleurectomy/decortication surgery that has been successfully used as a curative procedure in scores of mesothelioma cases. He was also instrumental to the creation of the video-assisted surgery thoracic (VATS) the lobectomy, which is now considered to be the gold standard treatment for lung cancer. This minimally-invasive procedure requires just three small incisions for the removal of diseased lung sections.
Flores published over 100 peer-reviewed journal articles as well as book chapters during his career treating mesothelioma. He has received numerous professional awards, including being named a New York and America Top Doctor. He has also participated in several clinical research studies. One of these focused on the efficacy of in mesothelioma neoadjuvant treatment.
A physical examination as well as blood tests and imaging can all be used to identify mesothelioma. In a majority of cases, patients do not notice symptoms until the disease has progressed to a late stage. They might experience chest, throat or abdomen pain or fatigue, coughing and breathing difficulties. A doctor can drain the excess fluid to test for the presence of cancer cells and determine whether a patient has the epitheliod, mixed or sarcomatoid type of mesothelioma.
Asbestos exposure is the primary cause of mesothelioma. People who are exposed to asbestos during the construction, maintenance, and repair of ships, power stations or factories are at a higher risk of mesothelioma development.
A multidisciplinary team can offer patients the most effective treatment for mesothelioma. Patients should also consider radiation specialists and medical oncologists who specialize in treating mesothelioma. These doctors can create plans for treating the cancer with chemotherapy and/or radiotherapy. Patients with mesothelioma must consult their physicians about the number of mesothelioma cancer cases they have dealt with.
Robert Cameron
Robert Cameron, a renowned mesothelioma expert, graduated from UCLA's medical school nearly 30 years ago. He completed his surgical residency at Cornell University Medical Center and the National Cancer Institute before starting his mesothelioma-specific specialty. Patients suffering from mesothelioma benefit from his expertise in lung-sparing surgery and minimally invasive procedures such as thorascopic surgeries. Cameron is a mesothelioma researcher and has published over 35 articles on thoracic and oncology.
He is also the chief of surgery for thoracic at both the University of California Los Angeles and West Los Angeles Veterans Affairs Medical Center mesothelioma program. He also serves as the chief of thoracic surgery at the University of California Los Angeles and the West Los Angeles Veterans Affairs Medical Center's mesothelioma clinic.
Dr. Cameron has helped thousands asbestos sufferers and is a leader in mesothelioma treatment. He is focused on improving the quality of mesothelioma treatments and making sure that patients have access to the best mesothelioma specialists. He also represents patients and their families throughout their treatment process.
Cameron is a mesothelioma specialist with experience in treating both peritoneal and pleural mesothelioma. Cameron is experienced in a number of mesothelioma surgical treatment options, including cytoreductive surgeries and hyperthermic intraperitoneal chemotherapeutic treatments and pleurectomy/decortication. He has also treated pericardial tumors, which involves surgical removal of tumors from the lining of heart and surrounding tissue.
It is crucial to choose a mesothelioma doctor with privileges at a cancer center that you can trust. A top specialist has the staff, equipment and clinical trials to provide the treatment you require. Additionally, it is important to bring any relevant work history documents and scans of your imaging to your appointment. You may also want to bring an individual from your family or a close friend along with you for assistance and to help remember important information at your appointment.
If you are not keen on surgery or are unable to undergo it, there are other alternatives for mesothelioma treatment, such as immunotherapy and radiation. Many mesothelioma specialists are skilled in coordinating these other treatment options that include surgery. The mesothelioma specialists at your cancer center can assist you in making these decisions after a mesothelioma diagnoses.
Raphael Bueno
Bueno is an expert in the treatment of thoracic tumors, including mesothelioma. He is currently trying to improve the way mesothelioma and other lung cancers are treated and treated. Bueno's research is helping physicians to better understand mesothelioma on a molecular scale. Accident Injury Lawyers can make it easier to diagnose mesothelioma and lead to new treatments.
Raphael Bueno, Chief of Thoracic Surgery and vice-chair of Surgery for Cancer Research in Brigham and Women's Hospital is committed to maintaining Brigham and Women's Hospital's position as a leader in mesothelioma research and treatment. Bueno is director of the hospital’s International Mesothelioma Program. He has a wide range of expertise when it comes to mesothelioma treatment, diagnosis and prevention.
While leadership, patient care and teaching have all been important aspects of his career, research has dominated his time at BWH. He has developed tests to assist surgeons in identifying mesothelioma-related tumors during a biopsy, and he is developing techniques to make the procedure less and less invasive. He is also researching the gender differences in mesothelioma and how tumors grow.
After graduating from Harvard Medical School, Bueno began his career as surgical intern at BWH. He worked alongside mesothelioma pioneer Dr. David Sugarbaker, and he gained a lot of knowledge about mesothelioma through his mentor. Following his training, he completed an oto-cardiothoracic surgery residency at Massachusetts General Hospital before returning to BWH to create a private surgical practice and a mesothelioma research lab.
One of his greatest achievements is developing iVats, a system that allows surgeons to precisely identify mesothelioma cancers and remove them during an extrapleural pneumonectomy. This technique is a significant improvement on the traditional approach which is often ineffective and requires more tissue to be removed than is necessary. The new method has also resulted in better outcomes for patients suffering from mesothelioma.
Bueno is an active participant in a number of clinical trials that discover new methods for mesothelioma diagnosis and treatment. He is an active member of the Dana-Farber Cancer Institute and has appointments at Brigham and Women's Faulkner Hospital and Carney Hospital. He is also an associate of the American College of Chest Physicians.
Paul Sugarbaker
Paul Sugarbaker is a nationally recognized mesothelioma specialist. He is well-known for his work in peritoneal mesothelioma and abdominal cancers. His innovative approach to treating this rare cancer and pushing the boundaries of treatment has helped improve survival rates. He created, refined and popularized the method of combining cancer surgery with heated chemotherapy to treat peritoneal mesothelioma. This unique procedure is now referred to as the Sugarbaker Method. He continues to travel around the world to teach young surgeons about this innovative procedure.
A mesothelioma specialist has years of experience treating asbestos-related conditions. They may also have experience with the most current mesothelioma treatment as well as clinical trials. Patients with mesothelioma should be prepared by providing medical records, a list questions and a desire to communicate to their first appointment with a specialist.
There are a variety of mesothelioma experts, and each mesothelioma physician will have their own specialization. They include thoracic surgeons general surgeons, pulmonologists, pathologists and radiation oncologists. Each of these mesothelioma specialists play a crucial role in the care of patients.
A specialist in thoracic surgery treats chest cancers, tumors, as well as other chest problems. They can perform lung surgeries to reduce tumors or improve breathing capabilities. They may also prescribe medication to ease symptoms or to increase the life expectancy.
As a mesothelioma expert, a thoracic surgeon can help patients with the most challenging treatment options. They can also aid patients in finding mesothelioma groups and other resources.
Paul Sugarbaker earned his undergraduate degree at Wheaton College, located in Illinois. He completed his surgical residency in Boston at Peter Bent Brigham Hospital, an affiliated program of Harvard University. He then moved to Atlanta, Georgia where he worked at Emory University for two years before returning to Washington, D.C.
Paul Sugarbaker is an internationally recognized cancer surgeon and specialist. He has been recognized as one of America's Top Doctors, and he is a part of a variety of professional organizations. He is best known for his aggressive pursuit for the cure for mesothelioma peritoneal, which led to the HIPEC procedure (heated intraperitoneal chemotherapy) that has been proved to prolong the lives of patients with this rare cancer.